Sierra Oncology Raises $135M Via Equity To Fund Lead Program Development

Sierra Oncology Inc SRRA has priced its underwritten public offering of 4.07 million shares at $27 per share and the pre-funded warrants at $26.999 per pre-funded warrant.

 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechNewsFinancingOfferingsSmall CapMoversTrading IdeasGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!